The Need to Develop Clinical Guidance for the Use of High-Sensitivity Cardiac Troponin in Pediatric and Neonatal Patients

Clin Chem. 2022 Jul 3;68(7):884-886. doi: 10.1093/clinchem/hvac072.

Authors

Alan Wang¹, Yader Sandoval², Fred S Apple³, James Homme⁴, Allan S Jaffe^{2

5}; IFCC Committee on Clinical Applications of Cardiac Bio-Markers

Collaborators

IFCC Committee on Clinical Applications of Cardiac Bio-Markers:
Fred S Apple, Allan S Jaffe, Jorge Ordoñez-Llanos, Paul O Collinson, Richard Body, Amy K Saenger, Peter A Kavsak, Torbjørn Omland, Kristin Moberg Aakre, Ola Hammarsten

Affiliations

¹ Division of Pediatric Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
² Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
³ Departments of Laboratory Medicine and Pathology, Hennepin Healthcare/Hennepin, County Medical Center and University of Minnesota, Minneapolis, MN, USA.
⁴ Department of Emergency Medicine, Mayo Clinic, Rochester, MN, USA.
⁵ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

PMID: 35703376
DOI: 10.1093/clinchem/hvac072

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers
Child
Humans
Infant, Newborn
Troponin I*
Troponin T*

Substances

Biomarkers
Troponin I
Troponin T